Transcriptomics

Dataset Information

0

Resistance to PRMT5 Inhibitor Targeted Therapy in MCL

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Homo sapiens

PROVIDER: GSE240726 | GEO | 2023/12/30

REPOSITORIES: GEO

Json Xml

Similar Datasets

Other Resistance to PRMT5 Inhibitor Targeted Therapy in MCL [WES]
2023-12-30 | GSE240725 | GEO
Transcriptomics Resistance to PRMT5 Inhibitor Targeted Therapy in MCL [RNA-seq]
2023-12-30 | GSE240555 | GEO
Genomics Oncogenic deregulation of EZH2 as an opportunity for targeted therapy in lung cancer
2015-11-01 | E-GEOD-70047 | biostudies-arrayexpress
Transcriptomics Towards epigenetic understanding and therapy of insulin resistance by intranuclear insulin
2014-05-23 | E-GEOD-57928 | biostudies-arrayexpress
Transcriptomics Therapy-Induced Developmental Reprogramming of Prostate Cancer Cells and Acquired Resistance
2016-03-11 | E-GEOD-66852 | biostudies-arrayexpress
Genomics Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy
2015-02-09 | E-GEOD-65763 | biostudies-arrayexpress
Transcriptomics Inhibition of the autocrine loop IL6-JAK2-STAT3-Calprotectin as targeted therapy for HR-/HER2+ breast cancers
2015-09-03 | E-GEOD-62251 | biostudies-arrayexpress
Transcriptomics Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance in breast cancer
2013-05-01 | E-GEOD-39418 | biostudies-arrayexpress
Transcriptomics Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for amyotrophic lateral sclerosis and frontotemporal dementia
2013-11-12 | E-GEOD-51741 | biostudies-arrayexpress
Genomics Overcoming Lineage Plasticity and AR-Targeted Therapy Resistance in ZNF397-Deficient Prostate Cancer via TET2 Inhibition
2024-04-05 | GSE230602 | GEO